Sabby Management Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 3
- Investments
- 35
- Portfolio
- 5
- Exits
- 35
Sabby Management General Information
Description
Sabby Management is a venture capital firm that specializes in seed, early stage and later stage investments. The firm prefers to invest in firms operating in the healthcare sector. It is based in Upper Saddle River, New Jersey and was founded in 2011.
Contact Information
Website
www.sabbycapital.com
Year Founded
2011
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Hedge Fund
PE/Buyout
Primary Office
- 10 Mountainview Road
- Suite 205
- Upper Saddle River, NJ 07458
- United States
+1 (646) 000-0000
Sabby Management Investments (35)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Ability | 27-Nov-2018 | PIPE | 000.00 | Other IT Services | Generating Revenue/Not Profitable | |
| 0000 00000000 | 12-Sep-2018 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | |
| 000000 0000 000000 | 30-May-2018 | 0000 | 0000 | Therapeutic Devices | Generating Revenue/Not Profitable | 000 00000 |
| 00000 000000000000 | 13-Feb-2018 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue/Not Profitable | |
| 0000 00000000 | 28-Apr-2017 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | |
| 0000 00000 | 29-Mar-2017 | 0000 | 000.00 | Surgical Devices | Generating Revenue/Not Profitable | |
| 0000000 | 19-Jul-2016 | 0000 | 0000 | Drug Discovery | Generating Revenue/Not Profitable | |
| 0000000 00000000 | 24-Mar-2016 | 0000 | 00.000 | Biotechnology | Generating Revenue/Not Profitable | |
| Soleno Therapeutics | 11-Jan-2016 | PIPE | 0000 | Other Devices and Supplies | Generating Revenue/Not Profitable | |
| Outlook Therapeutic | 29-Sep-2015 | Later Stage VC | 0000 | Drug Discovery | Generating Revenue/Not Profitable |
Sabby Management Exits (35)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Superconductor Technologies | 09-Sep-2021 | Merger/Acquisition | |
| 0000000 | 03-Dec-2020 | 000000 0000000000 | 0000 |
| 0000000 000000000 | 06-Oct-2020 | 000000 0000000000 | 0000 |
| 00000000000000 000 | 10-Oct-2019 | 000000 0000000000 | 00.000 |
| 00000000 000000000 | 22-Feb-2019 | 000000 0000000000 | 0000 |
| 0000000 | 21-Jun-2018 | 000 | 00000 |
| 00000 000000000000 | 21-Jun-2018 | 000 | 000.00 |
| 000000 00000000000 | 29-Mar-2018 | 000 | 000.00 |
| VistaGen Therapeutics | 13-Dec-2017 | Public Investment 2nd Offering | 0000 |
| Odonate Therapeutics | 07-Dec-2017 | IPO | 00000 |
Sabby Management Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialSabby Management Team (3)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Peter Yan | Chief Financial Officer | New York, NY | |||
| Robert Grundstein JD | Chief Operating Officer & General Counsel | 0 | New York, NY | ||
| Hal Mintz | Founder | 0 | New York, NY |
Sabby Management Co-Investors (21)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Deerfield Management | 2 | 0 |
|
|
|
| Bay City Capital | 0 |
|
|
||
| Domain Associates | 0 | 0 |
|
|
|
| Evercore Group | 0 |
|
|
||
| Palmetto Partners | 0 |
|
|